New light in Pandemrix and Narcolepsy

Markku Partinen and his team in Finland have just published a new study on the link between Narcolepsy and the vaccine given to prevent H1N1, Pandemrix. The full report in English can be read here:
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033723

Once again they show the narcolepsy appears very quickly and with quite profound symptoms. All those tested were positive for the HLA DQB1*0602 subtype. The team point out that the coverage of children in Sweden and Finland was between 67% and 80% which is far higher than other European
countries. This could explain why so many Swedish and Finnish children were found to have developed narcolepsy.

The paper mentions the use of ASO3 the adjuvant found in Pandemrix but declines to say if that was one of the causes or not. The report says;

The report makes two new statements;

1. That while isolated cases of narcolepsy have been discovered after children were vaccinated with something other than Pandemrix, there is no evidence of an increased risk of narcolepsy with any other vaccine.
2. The adjuvant in Pandemrix is very potent and for the first time in a scientific paper they speculate that the adjuvant was so strong that it included central nervous system affection. They do remain unable to say if this systemic response caused cell damage.

Finland is now seeing a 17-fold increase in the annual incidence of narcolepsy in children. A common feature in the 54 children diagnosed was that 50'had received Pandemrix within 8 months of onset of symptoms. The report's conclusions are clear;